Top Markets
Coin of the day
Ever Supreme Bio Technology Co., Ltd Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology Co., Ltd

6712
Rang in Aktien #13229
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
Aktienkurs
$4.99
Marktkapitalisierung
$508.03M
Veränderung (1 Tag)
-2.48%
Veränderung (1 Jahr)
2.10%
Land
TW
Handel Ever Supreme Bio Technology Co., Ltd (6712)

Kategorie

Kursverlauf für Ever Supreme Bio Technology Co., Ltd (6712)
Höchster Schlusskurs: $4.88 am 2026-08-01

Niedrigster Schlusskurs: $1.98 am 2018-10-01
Kursverlauf der Aktie von Ever Supreme Bio Technology Co., Ltd von 2018 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -4.84%
2025 8.48%
2024 -5.27%
2023 0.33%
2022 -5.52%
2021 21.39%
2020 20.06%
2019 82.02%
2018 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$541.78 38.56%
US
$1.02K 43.72%
NL
$121.01 -13.08%
AU
$137.89 472.40%
US
$749.90 5.87%
CH